MedinCell SA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:MedinCell SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C2804
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MedinCell SA (MedinCell) is a developer of therapeutic solutions for the healthcare market. The company develops and commercializes BEPO, a technology based on custom proprietary copolymers and a biocompatible solvent for long acting injectables. Its BEPO provides a controlled release of therapeutic molecules and can be used to improve the treatment for a variety of chronic diseases or short-term illnesses. MedinCell provides peptides and proteins delivery services. MedinCell offers products for various indications including schizophrenia, pain and inflammation, depression, anaesthesia, organ transplant, and others. The company works for profit and non-profit projects, and collaborates with partners including pharmas, physicians, biotech firms, academics and foundations. MedinCell is headquartered in Jacou, France.

MedinCell SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MedinCell SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MedinCell SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
MedinCell SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MedinCell SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
MedinCell SA, Medical Devices Deals, 2012 to YTD 2018 9
MedinCell SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
MedinCell SA, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
MedinCell Raises Funds through Financing 11
Partnerships 12
MedinCell Enters into Agreement with Sandoz International 12
Corbion and MedinCell Form Joint Venture 13
MedinCell SA – Key Competitors 14
MedinCell SA – Key Employees 15
MedinCell SA – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Corporate Communications 17
Jul 06, 2017: Dr. Sabri Markabi Joins MedinCell’s Supervisory Board 17
Product News 18
12/07/2017: MedinCell receives grant to develop long-acting injectable contraceptive 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
MedinCell SA, Pharmaceuticals & Healthcare, Key Facts 2
MedinCell SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MedinCell SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
MedinCell SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MedinCell SA, Deals By Therapy Area, 2012 to YTD 2018 8
MedinCell SA, Medical Devices Deals, 2012 to YTD 2018 9
MedinCell SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
MedinCell Raises Funds through Financing 11
MedinCell Enters into Agreement with Sandoz International 12
Corbion and MedinCell Form Joint Venture 13
MedinCell SA, Key Competitors 14
MedinCell SA, Key Employees 15
MedinCell SA, Other Locations 16
MedinCell SA, Subsidiaries 16

List of Figures
MedinCell SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
MedinCell SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
MedinCell SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
MedinCell SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
MedinCell SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MedinCell SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
MedinCell SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MedinCell SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
MedinCell SA, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[MedinCell SA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Oil & Gas Development Co Ltd (OGDC)
    Oil & Gas Development Co Ltd (OGDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • ConMed Corporation (CNMD):企業の財務・戦略的SWOT分析
    ConMed Corporation (CNMD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (874):製薬・医療:M&Aディール及び事業提携情報
    Summary Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (Guangzhou Baiyunshan Pharmaceutical) is a manufacturer of herbal medicine, chemical raw material medicine and preparation, biological medicine, and health products. The company also offers herbal tea, Chinese and Western medicine, intermed …
  • SMART Global Holdings, Inc. (SGH):企業の財務・戦略的SWOT分析
    SMART Global Holdings, Inc. (SGH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • PledPharma AB (PLED):企業の財務・戦略的SWOT分析
    Summary PledPharma AB (PledPharma) is a pharmaceutical company that discovers, manufactures, and develops drugs that protect the body against oxidative stress. The company discovers and develops Aladote and PledOx drugs. Its PledOX drug is used to prevent chemotherapy-induced side effects for colore …
  • The Binding Site Group Ltd:製品パイプライン分析
    Summary The Binding Site Group Ltd (Binding Site) is a clinical diagnostic tools supplier that concentrates on research, development, manufacturing and distribution of immunodiagnostic assays. The company’s product portfolio includes antibodies, antigens, bulk antisera, assays for plasma protein ana …
  • ADX Energy Ltd (ADX):石油・ガス:M&Aディール及び事業提携情報
    Summary ADX Energy Ltd (ADX) is an upstream oil and gas company that carries out energy exploration activities in North Africa and Europe. The company operates through three segments, namely, Tunisia Exploration and Evaluation, Romania Exploration and Evaluation and Italy Exploration and Evaluation. …
  • Ajman Bank (AJMANBANK):企業の財務・戦略的SWOT分析
    Ajman Bank (AJMANBANK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Foster Electric Co Ltd:企業の戦略・SWOT・財務情報
    Foster Electric Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Foster Electric Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Tohoku Electric Power Co Inc (9506):企業の財務・戦略的SWOT分析
    Tohoku Electric Power Co Inc (9506) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • ABB Ltd (ABBN):石油・ガス:M&Aディール及び事業提携情報
    Summary ABB Ltd (ABB) is a provider of industrial technologies. It offers products, systems, solutions, and services in electrification products, motion, industrial automation, industrial automation, and power grids. The company’s offerings harness power reliability, increase industrial productivity …
  • Inventec Corporation (2356):企業の財務・戦略的SWOT分析
    Inventec Corporation (2356) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • GE Energy Power Conversion Group:企業の戦略的SWOT分析
    GE Energy Power Conversion Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Buffalo Rock Company:企業の戦略・SWOT・財務情報
    Buffalo Rock Company - Strategy, SWOT and Corporate Finance Report Summary Buffalo Rock Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Mauna Kea Technologies SAS (MKEA)-医療機器分野:企業M&A・提携分析
    Summary Mauna Kea Technologies SAS (MKT) is a medical device company that develops, manufactures and distributes tools to visualize and detect cellular abnormalities during endoscopic procedures. The company’s product includes cellvizio. Its cellvizio is an endomicroscopy platform that provides micr …
  • Singapore Petroleum Co Ltd:企業の戦略的SWOT分析
    Singapore Petroleum Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Titan Pharmaceuticals Inc (TTNP)-医療機器分野:企業M&A・提携分析
    Summary Titan Pharmaceuticals Inc (Titan) is a biopharmaceutical company that develops therapeutics for the treatment of serious medical disorders. The company develops drugs using ProNeura, a proprietary drug delivery platform, for the treatment of chronic diseases. It product portfolio offers prob …
  • Saskatchewan Power Corp:企業の戦略的SWOT分析
    Saskatchewan Power Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • PT Pertamina (Persero):企業の戦略的SWOT分析
    PT Pertamina (Persero) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Bando Chemical Industries Ltd (5195):企業の財務・戦略的SWOT分析
    Bando Chemical Industries Ltd (5195) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆